Definitive Healthcare Corp. (NASDAQ:DH) Receives $3.94 Average PT from Analysts

Definitive Healthcare Corp. (NASDAQ:DH) has earned a consensus rating of “Hold” from the nine brokerages that are covering the stock, MarketBeat reports. Three investment analysts have rated the stock with a sell recommendation, four have issued a hold recommendation, one has issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $3.9417.

A number of equities analysts have recently issued reports on the stock. Canaccord Genuity Group lowered their target price on shares of Definitive Healthcare from $5.00 to $4.00 and set a “hold” rating on the stock in a research report on Monday, November 10th. William Blair raised shares of Definitive Healthcare to a “strong-buy” rating in a research report on Thursday, November 6th. Wall Street Zen cut shares of Definitive Healthcare from a “strong-buy” rating to a “buy” rating in a report on Sunday, December 28th. Morgan Stanley reissued an “underperform” rating and set a $3.50 price target on shares of Definitive Healthcare in a report on Thursday, December 18th. Finally, Barclays dropped their price target on Definitive Healthcare from $3.00 to $2.75 and set an “underweight” rating on the stock in a research report on Monday, December 8th.

Definitive Healthcare Stock Performance

Shares of DH stock opened at $2.55 on Thursday. The stock’s 50-day moving average is $2.62 and its two-hundred day moving average is $3.36. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.60 and a current ratio of 1.60. Definitive Healthcare has a 1 year low of $2.15 and a 1 year high of $5.68. The firm has a market cap of $360.47 million, a price-to-earnings ratio of -1.53 and a beta of 1.60.

Definitive Healthcare (NASDAQ:DH) last announced its earnings results on Thursday, November 6th. The company reported $0.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.06 by $0.01. The firm had revenue of $60.05 million during the quarter, compared to analysts’ expectations of $59.51 million. Definitive Healthcare had a positive return on equity of 3.30% and a negative net margin of 77.88%.Definitive Healthcare has set its FY 2025 guidance at 0.230-0.240 EPS and its Q4 2025 guidance at 0.050-0.060 EPS. Analysts predict that Definitive Healthcare will post 0.16 earnings per share for the current year.

Institutional Investors Weigh In On Definitive Healthcare

Several hedge funds have recently modified their holdings of DH. SG Americas Securities LLC acquired a new position in Definitive Healthcare in the 4th quarter valued at $46,000. Cambria Investment Management L.P. acquired a new position in shares of Definitive Healthcare during the third quarter worth about $145,000. Ariadne Wealth Management LP purchased a new position in Definitive Healthcare during the third quarter worth about $54,000. PharVision Advisers LLC acquired a new stake in Definitive Healthcare in the third quarter valued at about $120,000. Finally, Prelude Capital Management LLC purchased a new stake in Definitive Healthcare in the 3rd quarter valued at approximately $64,000. 98.67% of the stock is owned by institutional investors and hedge funds.

Definitive Healthcare Company Profile

Definitive Healthcare (NASDAQ:DH) is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.

The company’s flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities.